Effector CTLs eliminate tumor cells through two primary mechanisms: the perforin/granzyme pathway, wherein perforin facilitates granzyme B entry into target cells to induce apoptosis, and death receptor signaling, mediated via FasL–Fas and TRAIL–DR5 interactions that trigger caspase activation and cell death. This evidence concerns the gene PRF1 and neoplasm.